牛牛AI助手已提取核心信息
Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a series of transactions involving the company's common stock over the course of January 30 and 31, 2024. On January 30, Roberts exercised options to acquire 9,275 shares at no cost and subsequently sold 2,709 shares at $9.80 per share, resulting in a total market value of $26,548.20 for the disposed shares. The following day, Roberts acquired an additional 5,860 shares at a price of $2.69 per share. After these transactions, Roberts directly held a total of 32,850 shares of Altimmune common stock. Additionally, there are 15 shares held indirectly by Roberts' spouse.
Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a series of transactions involving the company's common stock over the course of January 30 and 31, 2024. On January 30, Roberts exercised options to acquire 9,275 shares at no cost and subsequently sold 2,709 shares at $9.80 per share, resulting in a total market value of $26,548.20 for the disposed shares. The following day, Roberts acquired an additional 5,860 shares at a price of $2.69 per share. After these transactions, Roberts directly held a total of 32,850 shares of Altimmune common stock. Additionally, there are 15 shares held indirectly by Roberts' spouse.
Altimmune, Inc. '的首席科学官M Scot Roberts在2024年1月30日和31日期间完成了一系列涉及公司普通股的交易。1月30日，罗伯茨行使期权免费收购了9,275股股票，随后以每股9.80美元的价格出售了2,709股股票，使已处置股票的总市值达到26,548.20美元。第二天，罗伯茨以每股2.69美元的价格又收购了5,860股股票。在这些交易之后，罗伯茨直接持有总计32,850股Altimmune普通股。此外，罗伯茨的配偶间接持有15股股份。
Altimmune, Inc. '的首席科学官M Scot Roberts在2024年1月30日和31日期间完成了一系列涉及公司普通股的交易。1月30日，罗伯茨行使期权免费收购了9,275股股票，随后以每股9.80美元的价格出售了2,709股股票，使已处置股票的总市值达到26,548.20美元。第二天，罗伯茨以每股2.69美元的价格又收购了5,860股股票。在这些交易之后，罗伯茨直接持有总计32,850股Altimmune普通股。此外，罗伯茨的配偶间接持有15股股份。
有用
没用